TP0502-B-Pharmaco-Scintigraphic-Study

NCT02306798 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: TP05

Sponsor

Tillotts Pharma AG